Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Omega Healthcare Investors Q1 2026 Earnings Call - FAD Surges 9.5%, Dividend Hike Looms as Genesis Bankruptcy Nears Resolution
Omega Healthcare Investors delivered a strong first quarter in 2026, with Adjusted FFO and FAD per share rising to $0.82 and $0.78 respectively, driven by aggressive capital deployment and a 10.9% wei...
- Omega Healthcare Investors reported Q1 2026 Adjusted FFO of $0.82 per share and FAD of $0.78 per share, reflecting a 9.5% year-over-year increase in FAD per share.
- The company raised its full-year 2026 Adjusted FFO guidance midpoint by $0.02 to $3.22 per share, citing strong revenue growth from new investments and annual escalators.
- Omega is selling 18 CommuniCare facilities in Maryland and West Virginia for $480 million at a 7.7% blended rent discount, aiming to enhance credit and redeploy capital into higher-yielding assets.
- +7 more takeaways
Constellium Q1 2026 Earnings Call - Record EBITDA and Raised 2026 Outlook Driven by Scrap Spreads and Aerospace Momentum
Constellium delivered a record first quarter for Adjusted EBITDA, excluding the non-cash impact of metal price lag, and raised its full-year 2026 guidance. The results were fueled by a highly favorabl...
- Constellium reported record first-quarter Adjusted EBITDA of $359 million, including a $97 million non-cash benefit from metal price lag, and $262 million excluding that impact, up 78% year-over-year.
- The company raised its full-year 2026 Adjusted EBITDA guidance (excluding metal price lag) to $900-$940 million and lifted free cash flow expectations to over $275 million.
- Aerospace shipments surged 13% year-over-year, driven by record OEM backlogs and strong demand for high-value-added proprietary alloys like aluminum-lithium solutions.
- +7 more takeaways
Boston Properties (BXP) Q1 2026 Earnings Call - AI Demand Drives Premier Office Outperformance
Boston Properties (BXP) delivered a strong Q1 2026, beating FFO guidance by $0.02 per share and raising its full-year outlook as AI-driven leasing demand surges. The company reported 1.14 million squa...
- FFO per share of $1.59 exceeded guidance by $0.02, prompting a raise in full-year 2026 FFO guidance to $6.90–$7.04 per share.
- Total leasing volume reached 1.14 million square feet in Q1, with AI and tech tenants driving nearly 80% of demand in San Francisco.
- In-service portfolio occupancy rose 70 basis points to 87.4%, with a 350 basis point gap between leased and occupied space signaling near-term upside.
- +7 more takeaways
Old Dominion Freight Line Q1 2026 Earnings Call - Service Gap Widens, Capacity Constraint Returns
Old Dominion Freight Line delivered another quarter of resilient service execution, but the revenue decline tells a story of a market stuck between a rocky start and a cautious recovery. The LTL giant...
- Revenue fell 2.9% year-over-year to $1.33 billion, with LTL tonnage down 7.7% but revenue per hundredweight up 5.7%, highlighting a successful yield management strategy despite volume weakness.
- Sequential tonnage growth accelerated sharply in February (+4.9%) and March (+4.6%), though April’s year-over-year decline of approximately 6.5% signals a cautious start to the second quarter.
- The operating ratio widened by 80 basis points to 76.2% in Q1 2026, driven by overhead deleveraging from lower revenue and rising general supplies, depreciation, and fuel costs.
- +7 more takeaways
Carpenter Technology Q3 FY2026 Earnings Call - Record Earnings Drive Margin Expansion and Aerospace Supply Chain Acceleration
Carpenter Technology delivered a record quarter in Q3 FY2026, with operating income surging 20% sequentially to $187 million and adjusted free cash flow reaching $124.8 million. The Specialty Alloys O...
- Record operating income of $187 million in Q3 FY2026, a 20% sequential increase and a new all-time high for the company.
- Specialty Alloys Operations (SAO) segment achieved a record 35.6% adjusted operating margin, marking the 17th consecutive quarter of margin expansion.
- Aerospace and defense sales rose 17% year-over-year and 13% sequentially, driven by accelerating OEM build rates and rising structural material orders.
- +12 more takeaways
AstraZeneca Q1 2026 Earnings Call - Pipeline Breakthroughs Offset LOE Headwinds as Tozorakimab Data Reshapes COPD Landscape
AstraZeneca delivered a solid Q1 2026, with total revenue up 8% and core operating profit rising 12%, driven by robust demand for oncology and rare disease assets. The quarter was defined by four posi...
- Total revenue grew 8% year-over-year, with core operating profit up 12%, reflecting strong underlying demand and operating leverage despite LOE headwinds in CVRM.
- Four positive phase III readouts were announced, led by Tozorakimab in COPD, which showed efficacy across broad patient populations regardless of eosinophil levels, challenging the status quo for biologic COPD treatments.
- Oncology revenue surged 16% to $6.8 billion, driven by double-digit growth in Tagrisso, Imfinzi/Imjudo (up 28%), Calquence (up 17%), and Enhertu (up 34%), which is now annualizing at a $5 billion run rate.
- +7 more takeaways
Wingstop Q1 2026 Earnings Call - Smart Kitchen and Loyalty Drive Profitability Despite Comp Headwinds
Wingstop delivered a resilient Q1 2026, posting double-digit adjusted EBITDA growth and 17% unit growth even as same-store sales declined 8.7% due to atypical winter weather and elevated gas prices. M...
- Same-store sales declined 8.7% in Q1 2026, driven by a four percentage point headwind from atypical winter weather closures and elevated gas prices, which disproportionately impacted the lower-income consumer base.
- Updated full-year domestic same-store sales guidance to a low single-digit decline, with expectations for a return to growth in the second half as macro pressures ease and strategic initiatives scale.
- Delivered double-digit adjusted EBITDA growth and 7.4% total revenue growth to $183.7 million, underscoring the resilience of the asset-light, highly franchised model.
- +7 more takeaways
H2O America Q1 2026 Earnings Call - $700M Equity Raise Funds Quadvest Acquisition and 2027 Capital Budget
H2O America delivered a solid first quarter with adjusted EPS of $0.50, in line with expectations, but masked underlying 15% organic growth by a higher share count from a massive $700 million equity r...
- Adjusted diluted EPS came in at $0.50, consistent with internal expectations and supportive of the full-year 2026 guidance of $3.08 to $3.18 per share.
- The company executed a $700 million equity offering, more than five times oversubscribed and priced at a tight 2.6% discount, effectively removing equity risk for the Quadvest acquisition and 2026-2027 capital budget.
- Management confirmed it will stay out of the equity markets, including the ATM program, through at least year-end 2027, relying on the board agreement portion of the March issuance and cash equivalents to fund operations.
- +9 more takeaways
SNDL Q1 2026 Earnings Call - Cannabis Market Softness Offset by Margin Expansion and Buybacks
SNDL reported a mixed Q1 2026 performance, with net revenue declining 4.4% year-over-year to CAD 196 million due to persistent demand softness in both its liquor and cannabis markets. Same-store sales...
- Net revenue declined 4.4% year-over-year to CAD 196 million, driven by same-store sales drops of 6.1% in liquor retail and 2.5% in cannabis retail.
- Cannabis operations revenue fell 14% year-over-year to CAD 29.4 million due to destocking at provincial boards and a sharp decline in B2B contract sales.
- Gross margin expanded by 20 basis points in liquor retail and 100 basis points in cannabis retail, offsetting broader revenue declines through pricing and product mix optimization.
- +9 more takeaways
MGP Ingredients Q1 2026 Earnings Call - Margin Expansion and Portfolio Rationalization Drive Strategic Reset
MGP Ingredients reported a challenging first quarter with sales declining 13% year-over-year to $106.4 million, driven by a difficult industry backdrop in whiskey and elevated operational costs in its...
- Consolidated sales of $106.4 million declined 13% year-over-year, in line with expectations, despite a challenging industry backdrop.
- Adjusted EBITDA of $15 million and adjusted EPS of $0.15 beat management guidance, validating the company's strategic execution.
- A $179.5 million non-cash impairment charge in the Branded Spirits segment drove a reported net loss of $134.8 million, obscuring underlying operational improvements.
- +7 more takeaways